Sarepta Therapeutics (SRPT) PT Raised to $200 at Piper Jaffray

January 30, 2019 4:37 AM EST Send to a Friend

Piper Jaffray analyst Edward Tenthoff ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Sarepta Therapeutics (SRPT) PT Raised to $200 at Piper Jaffray

Member Login

Free News Feed